Nanopolystyrene translocation and fetal deposition after acute lung exposure during late-stage pregnancy.
Fournier SB, D'Errico JN, Adler DS, Kollontzi S, Goedken MJ, Fabris L, Yurkow EJ, Stapleton PA. · 2020
Read Nanopolystyrene translocation and fetal deposition after acute lung exposure during late-stage pregnancy. by Fournier SB, D'Errico JN, Adler DS, Kollontzi S, Goedken MJ, Fabris L, Yurkow EJ, Stapleton PA. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7585297.txt.
Introduction
Fournier and co-authors test whether inhaled nanoplastic reaches fetal tissue in late pregnancy. Plastic particles have been found in indoor air. Their small size lets them be inhaled by people.
Pregnant rats were exposed on gestational day 19. They received 20 nm labeled polystyrene beads by airway. Dose was 2.64 × 1014 particles in total. Tissues were checked 24 hours later on day 20. Fetal and placental weights were lower by 7 and 8%. Particles appeared in maternal lung, heart and spleen. They also appeared in placenta and fetal organs. Fetal brain and kidney were among sites found. The results confirm lung-to-fetus transfer of plastic particles.
Catalog record
| CREATOR | Fournier SB, D'Errico JN, Adler DS, Kollontzi S, Goedken MJ, Fabris L, Yurkow EJ, Stapleton PA. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Nanopolystyrene translocation and fetal deposition after acute lung exposure during late-stage pregnancy By Sara B Fournier, Jeanine N D’Errico, Derek S Adler, Stamatina Kollontzi, Michael J Goedken, Laura Fabris, Edward J Yurkow, Phoebe A Stapleton Published in: Particle and Fibre Toxicology DOI: 10.1186/s12989-020-00385-9 ABSTRACT Abstract Background Plastic is everywhere. It is used in food packaging, storage containers, electronics, furniture, clothing, and common single-use disposable items. Microplastic and nanoplastic particulates are formed from bulk fragmentation and disintegration of plastic pollution. Plastic particulates have recently been detected in indoor air and remote atmospheric fallout. Due to their small size, microplastic and nanoplastic particulate in the atmosphere can be inhaled and may pose a risk for human health, specifically in susceptible populations. When inhaled, nanosized particles have been shown to translocate across pulmonary cell barriers to secondary organs, including the placenta. However, the potential for maternal-to-fetal translocation of nanosized-plastic particles and the impact of nanoplastic deposition or accumulation on fetal health remain unknown. In this study we investigated whether nanopolystyrene particles can cross the placental barrier and deposit in fetal tissues after maternal pulmonary exposure. Results Pregnant Sprague Dawley rats were exposed to 20 nm rhodamine-labeled nanopolystyrene beads (2.64 × 1014 particles) via intratracheal instillation on gestational day (GD) 19. Twenty-four hours later on GD 20, maternal and fetal tissues were evaluated using fluorescent optical imaging. Fetal tissues were fixed for particle visualization with hyperspectral microscopy. Using isolated placental perfusion, a known concentration of nanopolystyrene was injected into the uterine artery. Maternal and fetal effluents were collected for 180 min and assessed for polystyrene particle concentration. Twenty-four hours after maternal exposure, fetal and placental weights were significantly lower (7 and 8%, respectively) compared with controls. Nanopolystyrene particles were detected in the maternal lung, heart, and spleen. Polystyrene nanoparticles were also observed in the placenta, fetal liver, lungs, heart, kidney, and brain suggesting maternal lung-to-fetal tissue nanoparticle translocation in late stage pregnancy. Conclusion These studies confirm that maternal pulmonary exposure to nanopolystyrene results in the translocation of plastic particles to placental and fetal tissues and renders the fetoplacental unit vulnerable to adverse effects. These data are vital to the understanding of plastic particulate toxicology and the developmental origins of health and disease. Keywords: Nanoplastics, Translocation, Pregnancy, Maternal, Fetal, Polystyrene, Perfusion BACKGROUND Plastics are ubiquitous in modern society, used worldwide in a variety of applications ranging from manufacturing, packaging materials, personal products, and medical devices. Growing production and post-consumer plastic waste disposal contribute to the accumulation of plastic in landfills, waterways, and oceans [1]. In the natural environment, material fragmentation of bulk plastic waste by a combination of physical, chemical, and biological processes produces smaller particles referred to as microplastics (< 5 mm in a single dimension [2]) and nanoplastics (< 100 nm in a single dimension). Recent literature identified microplastics in atmospheric fallout [3, 4] and as a significant component of indoor air pollution [3]. These findings have raised concerns for potential adverse health effects of human nanoplastic particle inhalation [5]. In an occupational setting the potential for unintentional exposure to aerosolized micro- and nanoplastics is a critical issue. According to the United States Department of Labor Occupational Safety and Health Administration (OSHA) Regulation 1910.1000 Table Z pertaining to toxic and hazardous air contaminants, there are presently no occupational exposure limits for aerosolized micro- or nano-sized plastic particles, likely these particles are grouped into “particles not otherwise regulated” and/or “inert or nuisance dust” [6]. Current data on exposure to micro- and nanoplastics in a consumer or occupational context are very limited as the quantification of emissions in a background of ambient air particles cannot be accurately measured with existing technology [7] but may be estimated based on fragmentation of microplastics in the environment. A recent meta-analysis demonstrated that adult women are exposed to an average of 258 microplastic particles per day, of which inhalation accounts for 132 microplastic particles [8]. Unfortunately, very little is understood pertaining to the toxicology of nanoplastic particles; however, the physiological concerns of other engineered nanoparticles in a similar size range have been identified. Compared with like particles of a larger size, nanoparticles have the propensity to access deeper regions of the lung and cross biological barriers [9]. Recently, studies in mammalian models have identified maternal-to-offspring translocation of silver nanoparticles after pulmonary exposure, raising concerns for the risk of adverse health effects in dams and embryos/fetuses during pregnancy [10]. We have reported particle translocation of multi-walled carbon nanotubes (MWCNT) to the heart, kidneys, and other systemic tissues after inhalation of MWCNT aerosols in young adult male rats [11]. These studies demonstrate the probability of nanosized particles to translocate across pulmonary cell barriers to secondary organs, including the placenta. Furthermore, gold has been detected in the blood and urine of healthy human volunteers following acute inhalation of engineered gold nanoparticles [12]; also titanium was identified in the spleen and liver of young adult (12–13 weeks) and aged (19 months) rats exposed to a TiO2 nanostructured aerosol [13]. Although these studies identify the ionic dissociation and not the metallic particle, these outcomes may have relevance to the release of chemicals adsorbed to the surface of plastic particles in a biological environment [14]. While investigations of the impact of micro- and nanoplastic pollution in terrestrial ecosystems are limited, numerous studies have documented the effects of micro- and nanoplastics in the aquatic environment [5, 15, 16]. Mattsson et al. reported trophic transfer from prey to predator within a laboratory-simulated food chain where 53 nm polystyrene particles transferred from algae to the zooplankton Daphnia magna, and then to a freshwater fish [17]. Polystyrene nanoparticles (i.e., 42 nm) were identified in the yolk sac, gastrointestinal tract, liver, and pancreas of larvae and F1 embryos after maternal ingestion, providing evidence of maternal-offspring transfer in a non-placental vertebrate exposure model [18]. Cellular uptake of polystyrene nanoparticles (25 nm and 70 nm) has been reported in human alveolar epithelial A549 cells [19]. Nanopolystyrene exposure reduced cell viability, induced cell cycle S phase arrest, and up-regulation of pro-inflammatory cytokines and pro-apoptotic proteins [19]. Importantly, exposure duration, particle diameter, and concentration were key determinants of the toxicological effects of polystyrene nanoparticle exposure on alveolar epithelial cells [19]. While information about the risk of airborne micro- and nanoplastic particles to human health is limited, using an ex vivo human placental perfusion model, Wick et al. confirmed size-dependent maternal-to-fetal placental translocation of fluorescent polystyrene particles (50 nm, 80 nm, and 240 nm) [20]. Furthermore, Grafmueller et al. examined the bidirectional transfer of polystyrene particles using the ex vivo human placental perfusion model and observed placental translocation and particle accumulation in the syncytiotrophoblast of the placental tissue [21]. Investigators reported that nanoparticle translocation across the human placenta was dependent on particle physio-chemical characteristics and functionalization and was likely to involve an active, energy-dependent transport pathway [21]. While it is understood that nanoplastic particles are likely to reach the fetal tissues after maternal inhalation, the impact of maternal lung exposure to nanoplastic particles on fetal development and particle deposition within the fetus remains unclear [10, 21]. In this study, we examine the translocation and deposition/accumulation of nanopolystyrene particles in maternal and fetal tissues after a maternal pulmonary exposure in rats during late gestation. Furthermore, we